Herbal and dietary supplement hepatotoxicity

Clinical Liver Disease

Volumn 4, Issue 1, 2014, Pages 1-3

  Maddukuri, Vinaya C ^a   Bonkovsky, Herbert L ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPHOR; CASCARA; CHASO; GREATER CELANDINE; GREEN TEA EXTRACT; HERBACEOUS AGENT; JU BU HUAN; KAVA; PARACETAMOL; PHENTERMINE; PHOSPHODIESTERASE INHIBITOR; PYRROLIZIDINE; QUINONEIMINE; STEROID; THYROID HORMONE; UNCLASSIFIED DRUG; XIAO CHAI HU TANG;

ACTAEA RACEMOSA; ACUTE LIVER FAILURE; CHAPARRAL; DIET SUPPLEMENTATION; DISEASE SURVEILLANCE; DRUG CONTROL; DRUG MONITORING; DRUG SAFETY; EPHEDRA SINICA; FATTY LIVER; GERMANDER; HUMAN; IMPILA; KIDNEY METABOLISM; LIVER METABOLISM; LIVER TOXICITY; LIVER TRANSPLANTATION; MORINDA CITRIFOLIA; NONHUMAN; PATHOGENESIS; PENNYROYAL; PRIORITY JOURNAL; REVIEW; TOXIC HEPATITIS; TREATMENT OUTCOME; VISCUM ALBUM; XENOBIOTIC METABOLISM;

EID: 84904888666     PISSN: None     EISSN: 20462484     Source Type: Journal    
DOI: 10.1002/cld.364     Document Type: Review

References (10)

1. Strader DB, Navarro VJ, Seeff LB. Hepatotoxicity of Herbal Preparations. Chapter 26. In: Boyer TD, Manns MP, Sanyal AJ, eds. Zakim and Boyer's Hepatology 6th ed. Philadelphia, PA: Saunders-Elsevier; 2012: 462-475.
2. Verma S, Thuluvath PJ. Complementary and alternative medicine in hepatology: review of the evidence of efficacy. Clin Gastroenterol Hepatol 2007;5:408-416.
3. Bailey RL, Gahche JJ, Miller PE, Thomas PR, Dwyer JT. Why US adults use dietary supplements. JAMA Intern Med 2013;173:355-361.
4. Navarro VJ, Barnhart H, Bonkovsky HL, Davern TJ, Fontana RJ, Grant L, et al. The rising burden of herbal and dietary supplement-induced hepatotoxicity in the U.S.A. [Abstract #113, presented at Annual Meeting of AASLD, November 1-5, 2013, Washington, DC] Hepatology 58 [4, suppl]: 264A, 2013.
5. Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology 2014;146:914-928.
6. Bonkovsky HL, Jones DP, Russo MW, Shedlofsky SI. Drug-Induced Liver Injury. Chapter 25. In: Boyer TD, Manns MP, Sanyal AJ, editor. Zakim and Boyer's Hepatology 6th ed. Philadelphia, PA: Saunders-Elsevier; 2012: 417-461.
7. Seeff LB, Curto TM, Szabo G, Everson GT, Bonkovsky HL, Dienstag JL, et al. Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial. Hepatology 2008;47:605-612.
8. Strader DB, Bacon BR, Lindsay KL, La Brecque DR, Morgan T, Wright EC, et al. Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol 2002;97:2391-2397.
9. Klinsunthorn N, Petsom A, Nhujak T. Determination of steroids adulterated in liquid herbal medicines using QuEChERS sample preparation and high-performance liquid chromatography. J Pharm Biomed Anal 2011;55:1175-1178.
10. Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008;135:1924-1934, 1934.e1-e4.